Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Oct 11 04:00PM ET
2.44
Dollar change
+0.01
Percentage change
0.41
%
Index- P/E- EPS (ttm)-11.66 Insider Own3.53% Shs Outstand2.84M Perf Week3.39%
Market Cap6.93M Forward P/E- EPS next Y-5.87 Insider Trans0.00% Shs Float2.74M Perf Month0.41%
Income-25.17M PEG- EPS next Q-2.44 Inst Own11.03% Short Float6.24% Perf Quarter-42.26%
Sales0.00M P/S- EPS this Y50.36% Inst Trans53.18% Short Ratio4.28 Perf Half Y-47.26%
Book/sh6.91 P/B0.35 EPS next Y21.52% ROA-69.24% Short Interest0.17M Perf Year-64.17%
Cash/sh3.82 P/C0.64 EPS next 5Y- ROE-86.82% 52W Range2.12 - 15.75 Perf YTD-81.05%
Dividend Est.- P/FCF- EPS past 5Y18.25% ROI-138.85% 52W High-84.51% Beta1.86
Dividend TTM- Quick Ratio2.39 Sales past 5Y0.00% Gross Margin- 52W Low15.37% ATR (14)0.22
Dividend Ex-Date- Current Ratio2.39 EPS Y/Y TTM23.32% Oper. Margin0.00% RSI (14)46.48 Volatility7.10% 9.62%
Employees18 Debt/Eq0.03 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price25.00
Option/ShortNo / Yes LT Debt/Eq0.02 EPS Q/Q43.76% Payout- Rel Volume0.78 Prev Close2.43
Sales Surprise- EPS Surprise32.27% Sales Q/Q- EarningsAug 14 BMO Avg Volume39.89K Price2.44
SMA20-3.27% SMA50-0.64% SMA200-53.66% Trades Volume31,189 Change0.41%
Date Action Analyst Rating Change Price Target Change
Jul-18-22Resumed Oppenheimer Outperform $14
Oct-09-24 05:02PM
Oct-07-24 08:30AM
Oct-04-24 09:00AM
Sep-23-24 08:00AM
Sep-16-24 08:30AM
08:15AM Loading…
Sep-09-24 08:15AM
Sep-03-24 09:15AM
Aug-26-24 08:30AM
Aug-19-24 04:05PM
Aug-16-24 08:00AM
Aug-14-24 08:05AM
Aug-05-24 09:05AM
Aug-01-24 08:30AM
Jul-10-24 08:30AM
Jun-17-24 08:00AM
08:00AM Loading…
Jun-14-24 08:00AM
Jun-12-24 09:00AM
Jun-10-24 08:00AM
Jun-05-24 08:55AM
May-16-24 08:32AM
06:22AM
May-15-24 08:38AM
May-14-24 03:00AM
May-13-24 07:30AM
May-10-24 09:52PM
May-09-24 08:30AM
May-08-24 08:45AM
May-07-24 08:55AM
May-02-24 09:00AM
May-01-24 08:50AM
09:45AM Loading…
Apr-25-24 09:45AM
Apr-18-24 08:30AM
Apr-10-24 08:30AM
Mar-28-24 10:45AM
Mar-27-24 09:25AM
09:05AM
Mar-26-24 08:36AM
Mar-25-24 07:30AM
Mar-22-24 08:52PM
05:31PM
04:05PM
Mar-20-24 07:30AM
Mar-19-24 04:30PM
Mar-12-24 09:05AM
Jan-24-24 08:50AM
Dec-20-23 09:16PM
Dec-11-23 08:50AM
Nov-14-23 01:46PM
10:29AM
Nov-13-23 08:05AM
08:00AM
Nov-07-23 08:45AM
Nov-06-23 08:35AM
Oct-24-23 07:45AM
Oct-18-23 10:00AM
Oct-11-23 09:05AM
Oct-02-23 08:40AM
Sep-22-23 07:58AM
Sep-21-23 08:50AM
Sep-18-23 08:40AM
Sep-14-23 08:35AM
Sep-05-23 08:35AM
Aug-12-23 12:16AM
Aug-11-23 06:45AM
Aug-10-23 04:05PM
Aug-07-23 08:40AM
Aug-03-23 08:45AM
Jul-13-23 08:40AM
Jul-06-23 08:45AM
Jun-13-23 08:35AM
May-30-23 09:05AM
May-12-23 11:15AM
May-11-23 08:04AM
07:05AM
May-10-23 04:05PM
May-04-23 08:35AM
May-02-23 08:35AM
Apr-24-23 09:55AM
Apr-18-23 05:33PM
01:35PM
Mar-27-23 12:00PM
06:26AM
Mar-24-23 05:33AM
Mar-23-23 07:10AM
Mar-22-23 04:20PM
Mar-21-23 08:50AM
Mar-15-23 08:30AM
Mar-13-23 08:35AM
07:05AM
Mar-09-23 08:35AM
Mar-01-23 08:45AM
Feb-13-23 11:30AM
08:10AM
Jan-11-23 01:00PM
Jan-05-23 08:45AM
Dec-21-22 08:25AM
Dec-19-22 09:15AM
Dec-15-22 01:09PM
08:35AM
Dec-07-22 08:45AM
Moleculin Biotech, Inc. is a clinical stage pharmaceutical company. It engages in the business of growing a pipeline including phase 2 clinical programs for hard-to-treat cancers and viruses. The company was founded by Walter V. Klemp, Donald H. Picker, and Waldemar Priebe on July 28, 2015 and is headquartered in Houston, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Foster Jonathan P.Chief Financial OfficerDec 26 '23Buy0.6928,98620,00080,556Dec 27 07:32 AM
George Robert E.DirectorDec 26 '23Buy0.6914,49310,00014,660Dec 27 07:31 AM
KLEMP WALTER VCEO and PresidentDec 26 '23Buy0.69188,404129,999680,880Dec 27 07:31 AM